Cite
Cellular analyses for label-free and rapid HER2-positive cancer diagnosis based on SPRi-modified with nanobody.
MLA
Chen, Ribao, et al. “Cellular Analyses for Label-Free and Rapid HER2-Positive Cancer Diagnosis Based on SPRi-Modified with Nanobody.” Sensors & Actuators B: Chemical, vol. 395, Nov. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.snb.2023.134490.
APA
Chen, R., Li, Q., Zeng, Y., Sang, W., Tang, S., Jiao, Y., Zhou, J., Xu, Z., Shao, Y., Ying, M., & Xu, G. (2023). Cellular analyses for label-free and rapid HER2-positive cancer diagnosis based on SPRi-modified with nanobody. Sensors & Actuators B: Chemical, 395, N.PAG. https://doi.org/10.1016/j.snb.2023.134490
Chicago
Chen, Ribao, Qin Li, Youjun Zeng, Wei Sang, Shuo Tang, Yue Jiao, Jie Zhou, et al. 2023. “Cellular Analyses for Label-Free and Rapid HER2-Positive Cancer Diagnosis Based on SPRi-Modified with Nanobody.” Sensors & Actuators B: Chemical 395 (November): N.PAG. doi:10.1016/j.snb.2023.134490.